Founded in 2022, Respyr operates in Health Tech, offering a non-invasive lifestyle device designed to enhance personal wellness and health management. By analysing biomarkers in exhaled breath, it det...
Funding stage:
Seed
Last funding:
02/02/2024
Total funding:
$240.11K+
Revenue:
Investors
Respyr: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders33
Latest Filing Date30 May 2024- Funding Events19
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Respyr
As of 31 May 2024, Respyr's equity is held by 32 shareholders, with the top three being Ankur Jaiswal, Pushkar Bhagwat, and Suchita Mulye Kanaldekar.
Ankur Jaiswal holds the largest stake in Respyr at 38.8% as of 31 May 2024.
As of 31 May 2024, founders collectively hold 53.1% equity in Respyr.
As of 31 May 2024, investors collectively hold 20.3% equity in Respyr.
Respyr's ESOP pool stands at 9.1% of total equity as of 31 May 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links